日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate

rVSV拉沙热候选疫苗的安全性和免疫原性

Malkin, Elissa; Zaric, Marija; Kieh, Mark; Baden, Lindsey R; Fitz-Patrick, David; Marini, Arianna; Yun, Heejin; Hayes, Peter; Bromell, Rachel; Ayorinde, Morolayo; Fernandez, Natalia; Varma, Ruhani; Sigei, Faith; Ward, Matthew; Pindolia, Hema; Sewell, Shayna; Amini, Fahimah; Blie, Julie; Wilson, Barthalomew; Faley, Patrick; McCullough, John; Tokpah, Franklin; Wisseh, Cecelia; Towalid, Elvis; Hadawale, Swapnil; Sayeed, Eddy; Hunt, Devin; Keshavarzi, Nahid; Barin, Burc; Maljkovic Berry, Irina; Parks, Christopher L; Truter, Shobhna Gopal; Walker, Kathleen; Vekemans, Johan; Lehrman, Jennifer; Engelbrecht, Michelle; Malherbe, Mariette; Laufer, Dagna; Philiponis, Vincent; Higgs, Elizabeth; Mutua, Gaudensia; Fast, Patricia E; Gupta, Swati B

309 Factors influencing antibiotic use among ethnic minority communities in the UK: a qualitative study

309 影响英国少数族裔社区抗生素使用的因素:一项定性研究

Pelzer, Puck T; Stuck, Logan; Martinez, Leonardo; Richards, Alexandra S; Acuña-Villaorduña, Carlos; Aronson, Naomi E; Bonnet, Maryline; Carvalho, Anna C; Chan, Pei-Chun; Huang, Li-Min; Fang, Chi-Tai; Churchyard, Gavin; Corral-Londoño, Helena Del; Datta, Manjula; Espinal, Marcos A; Fielding, Katherine; Fiore-Gartland, Andrew J; Garcia-Basteiro, Alberto; Hanekom, Willem; Hatherill, Mark; Hill, Phillip C; Huerga, Helena; Jones-López, Edward C; Kritski, Afranio; Mandalakas, Anna M; Mangtani, Punam; Martins Netto, Eduardo; Mayanja, Harriet; Mazahir, Rufaida; Murray, Megan; Rangaka, Molebogeng; Scriba, Thomas; Singh, Jitendra; Singh, Sarman; Stein, Catherine M; Vekemans, Johan; Verhagen, Lilly M; Villalba, Julian A; Wajja, Anne; Watson, Basilea; White, Richard G; Cobelens, Frank G J; Ekezie, Winifred; Pan, Dan; Baggaley, Rebecca F; Chudasama, Yogini; Smith, Aiden J; Welford, Anneka; Hopwood, Ellen V; Jenkins, Sian; Butt, Ayesha A; Sze, Shirley; Nazareth, Joshua; Nellums, Laura; Khunti, Kamlesh; Pareek, Manish; Silva, Luisa; Gogoi, Mayuri; Lal, Zainab; Bird, Paul; George, Nisha; Pan, Daniel; Baggaley, Rebecca; Reilly, Holly; Czyznikowska, Barbara; Nellums, Laura; Pareek, Manish

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

SII-ChAdOx1 nCoV-19(COVID-19疫苗)的血清持久性:一项在印度成年人中进行的随机、对照、观察者盲法、II/III期免疫桥接研究的6个月随访结果

Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi Madhavi; Ramakrishnan, S R; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Budhawant, Chandrashekhar; Bonhomme, Cyrille J; Thakar, Madhuri; Kurle, Swarali N; Kelly, Elizabeth J; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Bhargava, Balram; Poonawalla, Cyrus S; Shaligram, Umesh; Kapse, Dhananjay; Gunale, Bhagwat

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?

在结核病疫苗有效性试验中测量间接减少传播效果:为什么以及如何测量?

Nelson, Kristin N; Churchyard, Gavin; Cobelens, Frank; Hanekom, Willem A; Hill, Philip C; Lopman, Benjamin; Mave, Vidya; Rangaka, Molebogeng X; Vekemans, Johan; White, Richard G; Wong, Emily B; Martinez, Leonardo; García-Basteiro, Alberto L

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

AZD1222 (ChAdOx1 nCoV-19) 在日本针对 SARS-CoV-2 的免疫原性和安全性:一项双盲、随机对照 1/2 期试验

Asano, Michiko; Okada, Hiroshi; Itoh, Yohji; Hirata, Hajime; Ishikawa, Kensuke; Yoshida, Erika; Matsui, Akiko; Kelly, Elizabeth J; Shoemaker, Kathryn; Olsson, Urban; Vekemans, Johan

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

与有症状和无症状SARS-CoV-2感染相关的保护因素

Feng, Shuo; Phillips, Daniel J; White, Thomas; Sayal, Homesh; Aley, Parvinder K; Bibi, Sagida; Dold, Christina; Fuskova, Michelle; Gilbert, Sarah C; Hirsch, Ian; Humphries, Holly E; Jepson, Brett; Kelly, Elizabeth J; Plested, Emma; Shoemaker, Kathryn; Thomas, Kelly M; Vekemans, Johan; Villafana, Tonya L; Lambe, Teresa; Pollard, Andrew J; Voysey, Merryn

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

ChAdOx1 nCoV-19 (AZD1222) 疫苗在南非 HIV 感染者和非感染者中预防 SARS-CoV-2 的安全性和免疫原性:一项随机、双盲、安慰剂对照的 1B/2A 期试验的中期分析

Madhi, Shabir A; Koen, Anthonet L; Izu, Alane; Fairlie, Lee; Cutland, Clare L; Baillie, Vicky; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Aley, Parvinder K; Bhikha, Sutika; Hermanus, Tandile; Horne, Elizea; Jose, Aylin; Kgagudi, Prudence; Lambe, Teresa; Masenya, Masebole; Masilela, Mduduzi; Mkhize, Nonhlanhla; Moultrie, Andrew; Mukendi, Christian K; Moyo-Gwete, Thandeka; Nana, Amit J; Nzimande, Ayanda; Patel, Faeezah; Rhead, Sarah; Taoushanis, Carol; Thombrayil, Asha; van Eck, Samuel; Voysey, Merryn; Villafana, Tonya L; Vekemans, Johan; Gilbert, Sarah C; Pollard, Andrew J; Moore, Penny L; Kwatra, Gaurav

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

一项在印度开展的2/3期、受试者盲法、观察者盲法、随机对照研究,旨在评估SII-ChAdOx1 nCoV-19(新冠病毒疫苗)在成年人中的安全性和免疫原性。

Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi Madhavi; Ramakrishnan, S R; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Vadakkedath, Rajeev; Bonhomme, Cyrille J; Thakar, Madhuri; Kurle, Swarali N; Kelly, Elizabeth J; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Bhargava, Balram; Shaligram, Umesh; Kapse, Dhananjay; Gunale, Bhagwat

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework

利用疫苗减少抗生素使用和预防抗菌素耐药性:世界卫生组织行动框架

Vekemans, Johan; Hasso-Agopsowicz, Mateusz; Kang, Gagandeep; Hausdorff, William P; Fiore, Anthony; Tayler, Elizabeth; Klemm, Elizabeth J; Laxminarayan, Ramanan; Srikantiah, Padmini; Friede, Martin; Lipsitch, Marc

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

ChAd63/MVA Pfs25-IMX313 在 I 期首次人体试验中的安全性和免疫原性

de Graaf, Hans; Payne, Ruth O; Taylor, Iona; Miura, Kazutoyo; Long, Carol A; Elias, Sean C; Zaric, Marija; Minassian, Angela M; Silk, Sarah E; Li, Lee; Poulton, Ian D; Baker, Megan; Draper, Simon J; Gbesemete, Diane; Brendish, Nathan J; Martins, Filipa; Marini, Arianna; Mekhaiel, David; Edwards, Nick J; Roberts, Rachel; Vekemans, Johan; Moyle, Sarah; Faust, Saul N; Berrie, Eleanor; Lawrie, Alison M; Hill, Fergal; Hill, Adrian V S; Biswas, Sumi